Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Br J Med Med Res ; 2016; 15(10):1-6
Article in English | IMSEAR | ID: sea-183166

ABSTRACT

Aims: To re- evaluate the use, effectiveness, acceptability and side effects of depot medroxyprogesterone acetate in Port Harcourt, Southern Nigeria. Study Design: Descriptive retrospective analysis. Place and Duration of Study: Family planning clinic, University of Port Harcourt Teaching Hospital, (UPTH), Port Harcourt Nigeria, between 1st January 2004 and 31st December, 2013. Methodology: The case files of all new clients who accepted and used depot medroxyprogesterone acetate at the UPTH were retrieved and their data including the socio-demographic characteristics, side effects, reasons for family planning extracted, coded and entered into a data bank and analysed using SPSS for windows 19.0 version and results expressed in percentages and presented in tables and figures. Results: Six hundred and seventy seven clients out of the total of 7001 new acceptors of contraception during the study period used depot medroxyprogesterone acetate (DMPA) giving an uptake rate of 9.7%. Three hundred and fifty three (52.1%) used it for child spacing while 324 (47.9%) used it for terminal fertility control. Secondary amenorrhea remained the commonest side effect occurring in 503 (74.3%) women. Up to 482 (71.2%) clients were lost to follow up, 43 (6.5%) discontinued voluntarily while 145 acceptors continued to use DMPA, giving a continuation rate of 22.5%. No unintended pregnancy occurred at the end of the observation period, giving a Pearl Index of 0/100 woman years. Conclusion: Depot medroxyprogesterone acetate is highly effective and safe method of fertility control but with declining acceptability, high default and low continuation rates.

2.
Br J Med Med Res ; 2014 June; 4(16): 3132-3139
Article in English | IMSEAR | ID: sea-175242

ABSTRACT

Aims: To re-evaluate intrauterine contraceptive use in Port Harcourt, Southern Nigeria and determine the uptake rate, effectiveness, side effects and discontinuation rate of IUCD. Study Design: Descriptive retrospective analysis. Place and Duration of Study: Family planning clinic, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria, between 1st January 2007 to 31st December, 2011. Methodology: The case files of all the clients who accepted intrauterine contraceptive device at the UPTH within the study period were retrieved from the record section of the family planning clinic and studied. Data on the client’s socio-demographic characteristics, complications and reasons for contraception and discontinuation were extracted, entered into SPSS for windows 11.0 version and analysed. Results: Of the 1, 434 new acceptors of contraception during this period, 366 accepted intra uterine contraceptive device giving an uptake rate of 25.5%. The mean age of the clients was 33.32±4.2 years and all were parous. The common complications were menorrhagia and vaginal discharge in 29 (26. 6%) each, abdominal pain in 28 (25.7%) and secondary amenorrhea in 10(9.2%) clients. One unintended pregnancy occurred giving a pearl pregnancy rate of 0.27 per 100 woman years. Up to 108 clients discontinued IUCD use, giving a discontinuation rate of 29.5%. Conclusion: IUCD is a highly effective and safe contraceptive method with a prevalence rate of 25.5% and discontinuation rate of 29.5% in Port Harcourt, southern Nigeria.

SELECTION OF CITATIONS
SEARCH DETAIL